Neurochem Res. 2010 Oct; 35(10) : 1522-9. Epub 2010 Jul 24. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson’s disease. Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.…

Gene Ther. 2010 Sep 30. [Epub ahead of print] Progress and prospects: stem cells and neurological diseases. Gögel S, Gubernator M, Minger SL. Wolfson Centre for Age-Related Diseases, Guy’s Campus, King’s College London, London, UK. Abstract The central nervous system has limited capacity of regenerating lost tissue in slowly progressive, degenerative neurological conditions such as…

Neurosurg. 2010 Sep; 113(3) : 648-55. Skin-derived precursors differentiating into dopaminergic neuronal cells in the brains of Parkinson disease model rats. Higashida T, Jitsuki S, Kubo A, Mitsushima D, Kamiya Y, Kanno H. Department of Neurosurgery, Yokohama City University, School of Medicine, Yokohama, Kanagawa, Japan. tets018@gmail.com Abstract OBJECT: In the authors’ previous study, they observed…

J Neurosci Res. 2010 Sep; 88(12) : 2669-81. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson’s disease. Glavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC. Department of Pediatrics, Neurobiology Program, Children’s Memorial Research Center, Feinberg School of Medicine,…

Transl Res. 2010 Sep; 156(3) : 155-60. Epub 2010 Jul 23. Translation of stem cell therapy for neurological diseases. Schwarz SC, Schwarz J. Department of Neurology, University of Leipzig, Leipzig, Germany. Abstract “Regenerative medicine” hopefully will provide novel therapies for diseases that remain without effective therapy. This development is also true for most neurodegenerative disorders…

Appl Biochem Biotechnol. 2010 Sep 5. [Epub ahead of print] In Vivo Evaluation of Cerebral Transplantation of Resovist-Labeled Bone Marrow Stromal Cells in Parkinson’s Disease Rats Using Magnetic Resonance Imaging. Guo J, Shen JK, Wang L, Xiao L, Zhang RJ, Luo WF, Gong ZG, Sun J, Xu H, Sirois P, Li K. Department of Radiology,…

Biochem Soc Trans. 2010 Aug; 38(4) : 1046-50. High-content screening of small compounds on human embryonic stem cells. Barbaric I, Gokhale PJ, Andrews PW. Centre for Stem Cell Biology, University of Sheffield, Western Bank, Sheffield S10 2TN, UK. Abstract Human ES (embryonic stem) cells and iPS (induced pluripotent stem) cells have been heralded as a…

Cell Reprogram. 2010 Aug; 12(4) : 447-61. Directed differentiation into neural lineages and therapeutic potential of porcine embryonic stem cells in rat Parkinson’s disease model. Yang JR, Liao CH, Pang CY, Huang LL, Lin YT, Chen YL, Shiue YL, Chen LR. Division of Physiology, Livestock Research Institute, Council of Agriculture, Executive Yuan, Tainan, Taiwan, ROC.…

Curr Opin Neurol. 2010 Aug; 23(4) : 426-32. Cell transplantation in Parkinson’s disease: problems and perspectives. Allan LE, Petit GH, Brundin P. Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund, Sweden. Abstract PURPOSE OF REVIEW: We review recent experiments conducted using embryonic tissue and stem cell transplants in experimental models of Parkinson’s disease. We…

Stem Cells. 2010 Aug; 28(8) : 1326-37. A small synthetic cripto blocking Peptide improves neural induction, dopaminergic differentiation, and functional integration of mouse embryonic stem cells in a rat model of Parkinson’s disease. Lonardo E, Parish CL, Ponticelli S, Marasco D, Ribeiro D, Ruvo M, De Falco S, Arenas E, Minchiotti G. Stem Cell Fate…